The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

America ’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient access to breakthrough therapies. Innovators are also relying on these strong protections to discover new medical advances that will keep patients healthy during this pandemic and after.

Source: The Catalyst - October 7, 2020 Category: Pharmaceuticals Authors: Tom Wilbur Tags: Research and Development Intellectual Property IP Explained Coronavirus Source Type: news